Longitudinal Association Between Markers of Liver Injury and Mortality in COVID‐19 in ChinaFang Lei, Yufeng Yuan, Chengzhang Yang et al.|Hepatology|2020Cited by 448
Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart diseaseWenxin Wang, Manli Hu, Hui Liu et al.|Cell Metabolism|2021Cited by 223
Metformin Is Associated with Higher Incidence of Acidosis, but Not Mortality, in Individuals with COVID-19 and Pre-existing Type 2 DiabetesXu Cheng, Hongliang Li, Ye-Mao Liu et al.|Cell Metabolism|2020Cited by 167
The Neutrophil-to-Lymphocyte Ratio Determines Clinical Efficacy of Corticosteroid Therapy in Patients with COVID-19Jingjing Cai, Hongliang Li, Haomiao Li et al.|Cell Metabolism|2021Cited by 134
Kidney Function Indicators Predict Adverse Outcomes of COVID-19Ye-Mao Liu, Hongliang Li, Jing Xie et al.|Med|2020Cited by 124